Non-AIDS defining malignancies or the sleeping giant: An update;Tumores no definitorios de sida o el gigante dormido: Actualización

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 31, Issue 5, 2013, Pages 319-327

  Valencia Ortega, M Eulalia ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Cancer and HIV infection; Comorbidity and HIV; Non AIDS defining malignancies

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LIVER CANCER; LUNG CANCER; MIXED INFECTION; NON HUMAN IMMUNODEFICIENCY VIRUS INFECTION DEFINING MALIGNANCY; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; TREATMENT RESPONSE; TUMOR VIRUS; VIRUS LOAD;

EID: 84879985801     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2012.03.015     Document Type: Review

References (114)

1. E.P. Simard, and E.A. Engels Cancer as cause of death among people with AIDS in the United States Clin Infect Dis 51 2010 957 962
2. M. Hensel, A. Goetzenich, T. Lutz, A. Stoehr, A. Moll, and J. Rockstroh HIV and cancer in Germany Dtsch Arzlebl Int 108 2011 117 122
3. J.L. Long, E.A. Engels, R.D. Moore, and K.A. Gebo Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV infected individuals AIDS 22 2008 489 496
4. A. Monforte, D. Abrams, C. Prader, R. Weber, P. Reiss, and F. Bonnet HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies AIDS 22 2008 2143 2153
5. F. Bonnet, C.h. Lewden, T.h. May, L. Heripret, E. Jougla, and S. Bevilacqua Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy Cancer 101 2004 317 324
6. CDC Classification system for human T lymphotropic virus type III/lymphadenophaty-associated virus infections MMWR 35 1986 334 339
7. CDC 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults MMWR 41 RR-17 1992 1 19
8. E.P. Simard, R.M. Pfeiffer, and E.A. Engels Spectrum of cancer risk late after AIDS in the United States Arch Intern Med 170 2010 1337 1345
9. P. Patel, D.L. Hanson, P.S. Sullivan, R.M. Novak, A.C. Moorman, and T.C. Tong Incidence of types of cancer among HIV-infected persons compared with the general population in the United States 1992-2003 Ann Intern Med 148 2008 728 736
10. M. Frisch, R.J. Biggar, E.A. Engels, J.J. Goedert for the AIDS-Cancer match registry study group Association of cancer with AIDS-related immunosuppression in adults JAMA 285 2001 1736 1745
11. M. Herida, M. Mary-Krause, R. Kaphan, J. Cadranel, I. Poizot-Martín, and Ch. Rabaud Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus infected patients J Clin Oncol 21 2003 3447 3453
12. M.S. Shiels, S.R. Cole, G.D. Kirk, and Ch. Poole A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals J Acquir Immune Defic Syndr 52 2009 611 622
13. J. Galceran, R. Marcos-Gragera, M. Soler, A. Romaguera, A. Ameijide, and A. Izquierdo Cancer incidence in AIDS patients in Catalonia, Spain Eur J Cancer 43 2007 1085 1091
14. J. Tomás Navarro, J.M. Ribera, J. Grau, C. Frías, M. Vaquero, and G. Sirera Enfermedad de Hodgkin en pacientes infectados por el virus de la inmunodeficiencia humana. Estudio de 15 casos Med Clin (Barc) 114 2000 19 21
15. F. Rodriguez-Arrondo, M.A. von Wichmann, J.A. Iribarren, O. Ferrero, J. Muñoz, and K. Aguirrebengoa Cohorte progresiva de tumores no definitorios de SIDA. Datos a 4 años. Grupo SEINORTE III Congreso Nacional de GESIDA y 5. Reunión Docente de la RIS. Sevilla 2011 Abstract OR-12
16. C.W. Wester, J.R. Koethe, B.E. Sheperd, S.E. Stinnette, P.F. Rebeiro, and A. Kipp Non-AIDS defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting AIDS 25 2011 1471 1479
17. N. Dauby, S. De Wit, V.C. Delforge Necsoi, and N. Clumeck Characteristics of non-AIDS defining malignancies in the HAART era: a clinic-epidemiological study J Intern AIDS Soc 14 2011 16 22
18. Pantanowitz L. Overview of non-AIDS-defining malignancies in HIV infection. Section Editor: Dezeube BJ; Deputy Editor: Ross ME. [consultado 27 Feb 2012] Disponible en: www.uptodate.com 2011
19. S.T. Lim, and A.M. Levine Non-AIDS-Defining cancers and HIV infection Curr Infect Dis Rep 7 2005 227 234
20. K.J. Cremer, S.B. Spring, and J. Gruber Role of human immunodeficiency virus type 1 and other viruses in malignancies associated with acquired immunodeficiency disease syndrome J Natl Cancer Inst 82 1990 1016 1024
21. E. Kieff Current perspectives on the molecular pathogenesis of virus-induced cancers in human immunodeficiency virus infection and acquired immunodeficiency syndrome J Natl Cancer Inst Monogr 23 1998 7 14
22. B. Ensoli, G. Barillari, S.Z. Salahuddin, R.C. Gallo, and F. Wong-Staal Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients Nature 345 1990 84 86
23. A. Albini, G. Barillari, R. Benelli, R.C. Gallo, and B. Ensoli Angiogenic properties of human immunodeficiency virus type 1 Tat protein Proc Natl Acad Sci U S A 92 1995 4838 4842
24. A. Kesselring, L. Gras, C. Smit, G. van Twillert, A. Verbon, and P. Reiss Immunodeficiency as a risk factor for non-AIDS defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy Clin Infect Dis 52 2011 1458 1465
25. J. Reekie, J. Gatell, I. Yust, E. Bakowska, A. Rakhmanova, and M. Losso Fatal and non-fatal AIDS and non-AIDS events in HIV-1 positive individuals with high CD4 counts according to viral load strata AIDS 25 2011 2259 2268
26. A.M. Mayor, M.A. Gómez, E. Ríos Olivares, and R.F. Hunter-Mellado AIDS-defining neoplasm prevalence in a cohort of HIV-infected patients, before and after highly active antiretroviral therapy Ethnic Dis 18S2 2008 189 194
27. M. Silverberg, W. Leyden, C. Chao, L. Xu, B. Tang, and M. Horberg Infection related non-AIDS-defining risk in HIV-infected and uninfected persons 16th CROI Montreal 2009 Abstract 30
28. G. Riva, P. Barozzi, G. Torelli, and M. Luppi Immunological and inflammatory features of Kaposi's sarcoma associated herpesvirus/human herpesvirus-8 associated neoplasias AIDS Rev 12 2010 40 51
29. D.H. Osmond, S. Buchbinder, A. Cheng, A. Graves, E. Vittinghoff, and C.K. Cossen Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic JAMA 287 2002 221 225
30. J.M. Ribera, and J.T. Navarro Herpes virus y cáncer. Virus de Epstein-Barr. Linfoma de Burkitt y otros linfomas. Carcinoma indiferenciado de la nasofaringe J. González Lahoz, R. Fernández-Muñoz, A.J. Moyano Jato, Virus y cáncer 2004 InyeccMedia Madrid 25 38
31. E. Chiao, C. Hartman, and T. Giordano The risk of HPV-related cancers compared to other AIDS-defining malignancies in US veterans 17th CROI San Francisco 2010 Abstract 764
32. A. Rapose Human papillomavirus and genital cancer Indian J Dermatol Venereol Lepr 23 2009 6 24 4
33. E.A. Engels Non-AIDS defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities AIDS 23 2009 875 888
34. L. Pantanowitz, and B.J. Dezube Evolving spectrum and incidence of non-AIDS-defining malignancies Curr Opin HIV AIDS 4 2009 27 34
35. E.A. Engels, R.M. Pfeiffer, J.J. Goedert, P. Virgo, T.S. McNeel, S.M. Scoppa for the HIV/AIDS Cancer Match Study Trends in cancer risk among people with AIDS in the United States 1980-2002 AIDS 20 2006 1645 1654
36. G.M. Clifford, J. Polesel, M. Rickenbach, L. Dal Masso, O. Keiser, A. Kofler on behalf of the wiss Cohort Study Cancer risk in the Swiss HIV cohort study: associations with immunodeficiency, smoking, and highly antiretroviral therapy J Natl Cancer Inst 97 2005 425 432
37. A. Burgi, S. Brodine, S. Wegner, M. Milazzo, M.R. Wallace, and K. Spooner Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals Cancer 104 2005 1505 1511
38. M.S. Shiels, R.M. Pfeiffer, and E.A. Engels Age al cancer diagnosis among persons with AIDS in the United States Ann Intern Med 153 2010 477 479
39. M.S. Shiels, R.M. Pfeiffer, and E.A. Engels Do people with AIDS develop cancer at younger ages than general population? 17th CROI San Francisco 2010 Abstract 757
40. G.M. Allarice, D.J. Hole, D.H. Brewster, J. Boyd, and D.J. Goldberg Incidence of malignant neoplasms among HIV-infected persons in Scotland Br J Cancer 89 2003 505 507
41. R.J. Bedimo, A. McGinnis, M. Dunlap, M.C. Rodriguez-Barradas, and A.C. Justice Incidence of non-AIDS-defining malignancies in HIV-infected versus non-infected patients in the HAART era: impact of immunosuppression J Acquir Immune Defic Syndr 52 2009 203 208
42. N.A. Hessol, S. Pipkin, S. Schwarcz, R.D. Cress, P. Bacchetti, and S. Scheer The impact of highly antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS Am J Epidemiol 165 2007 1143 1153
43. L.D. Thompson, S.I. Fisher, W.S. Chu, A. Nelson, and S.L. Abbondanzo HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases Am J Clin Pathol 121 2004 727 738
44. M. Corti, M.F. Villafane, N. Trione, and M. Narbaitz Linfoma de Hodgkin asociado al virus de la inmunodeficiencia humana tipo 1: hallazgos epidemiológicos, clínicos e histopatológicos de 18 pacientes Med Clin (Barc) 124 2005 116 117
45. T. Powles, D. Robinson, J. Stebbing, J. Shamash, M. Nelson, and B. Gazzard Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection J Clin Oncol 27 2008 884 890
46. M.J. Silverberg, and D.I. Abrams Do antiretrovirals reduce the risk of non-AIDS defining malignancies? Curr Opin HIV AIDS 4 2009 42 51
47. M. Spina, A. Carbone, A. Gloghini, D. Serraino, M. Berretta, and U. Tirelli Hodgkin's disease in patients with HIV infection Advanc Haematol 2011 2011. pii 402682. Epub 2010 Sep 23 doi:10.1155/2011/402682
48. R. Rubio Hodgkin's disease associated with human immunodeficiency virus infection: a clinical study of 46 cases Cancer 73 1994 2400 2407
49. J. Berenguer, P. Miralles, J.M. Ribera, R. Rubio, E. Valencia, and B. Mahillo Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy J Acquir Immune Defic Syndr 47 2008 422 428
50. C. Hoffmann, K.U. Chow, E. Wolf, G. Faetkenheuer, H.J. Stellbrink, and J. van Luzen Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease Br J Haematol 125 2004 455 462
51. J.M. Connors Positron emission tomography in the management of Hodgkin lymphoma Hematology (Am Soc Hematol Educ Program) 2011 2011 317 322
52. D. Hasenclever, and V. Diehl A prognostic score for advanced Hodgkin's disease N Engl J Med 339 1998 1506 1514
53. B. Xicoy, J.M. Ribera, P. Miralles, J. Berenguer, R. Rubio, and B. Mahillo Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma Haematologica 92 2007 191 198
54. B. Xicoy, J.M. Ribera, P. Miralles, J. Berenguer, R. Rubio, and B. Mahillo Limited prognostic value of the international prognostic score in advanced stage human immunodeficiency virus infection-related Hodgkin lymphoma treated with the doxorubicin, bleomycin, vinblastine and dacarbazine regimen Leuk Lymph 50 2009 1718 1720
55. J.L. Díez-Martín, P. Basalobre, A. Re, M. Michieli, J.M. Ribera, and C. Canals Comparable survival between HIV+ and HIV- non Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation Blood 113 2009 6011 6014
56. P. Miralles, J. Berenguer, J.M. Ribera Santasusana, F. Calvo, J. Díaz Mediavilla, and J.L. Díez-Martín Recomendaciones de GESIDA/PETHEMA para el diagnóstico y tratamiento de los linfomas en los pacientes infectados por el VIH Med Clin (Barc) 130 2008 300 311
57. C. Hoffman, M. Sabransky, C. Wyen, A. Baumgarten, J. Rockstroh, and J. Bogner Mortality remains high in HIV-associated lung cancer 18th CROI Boston 2011 Abstract 868
58. A.K. Chaturvedi, R.M. Pfeiffer, L. Chang, J.J. Goedert, R.J. Biggar, and E.A. Engels Elevated risk of lung cancer among people with AIDS AIDS 21 2007 207 213
59. A. Zuchetto, B. Suligoi, A. De Paoli, S. Pennazza, J. Polesel, and S. Bruzzone Eccess mortality for non-AIDS-defining cancers among people with AIDS Clin Infect Dis 51 2010 1099 1101
60. C.M. Tammemagi, C. Neslund-Dudas, M. Simoff, and P. Kvale Impact of comorbidity on lung cancer survival Int J Cancer 103 2003 792 802
61. S. Colette D:A:D Study group Association between modifiable and non-modifiable risk factors and specific causes of death in the HAART era: the data collection on adverse events of anti-HIV drugs study 16th CROI Montreal 2009 Abstract 145
62. G.M. Clifford, M. Lise, S. Franceschi, M. Egger, C. Bouchardy, and D. Korol Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection Br J Cancer 106 2012 447 452
63. K. Sigel, J. Wisnivesky, A. Justice, S. Brown, A. Butt, and S. Crystal HIV infection is an independent risk factor for lung cancer 17th CROI San Francisco 2010 Abstract 30
64. A.M. Levine, E.C. Seaberg, N.A. Hessol, S. Preston-Martin, S. Silver, and M.H. Cohen HIV as a risk factor for lung cancer in women: data from the women's interagency HIV study J Clin Oncol 28 2010 1514 1519
65. T. Powles, C. Thirwell, T. Newson-Davis, M. Nelson, P. Shah, and S. Cox Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era HAART Br J Cancer 89 2003 457 459
66. E.A. Engels, M.V. Brock, J. Chen, C.M. Hooker, M. Gillison, and R.D. Moore Elevated incidence of lung cancer among HIV-infected individuals J Clin Oncol 24 2006 1383 1388
67. J. Palefsky Human papillomavirus-related disease in people with HIV Curr Opin HIV AIDS 4 2009 52 56
68. J.R. Daling, N.S. Weiss, T.G. Hislop, C. Maden, R.J. Coates, and K.J. Sherman Sexual practices, sexually transmitted diseases and the incidence of anal cancer N Engl J Med 317 1987 973 977
69. A.K. Chaturvedi, M.M. Madeleine, R.J. Biggar, and E.A. Engels Risk of human papillomavirus-associated cancers among persons with AIDS J Natl Cancer Inst 101 2009 1120 1130
70. D. Parés, J. Mullerat, and M. Pera Neoplasia intraepitelial anal Med Clin (Barc) 127 2006 749 755
71. Palacios R, Polo R, coordinadores. Documento de Consenso del Grupo de Estudio del Sida (GESIDA)/Plan Nacional sobre el Sida (PNS) sobre las infecciones de transmisión sexual en pacientes con infección por el VIH. Enferm Infecc Microbiol Clin. 2011;29:286.e1-19.
72. Piketty Ch, A. Si-Mohamed, E. Lanoy, S. Trabelsi, R. Tubiana, and C. Rouzioux 24 months of cART is not associated with a reduction of anal HPV infection in HIV+ MSM 18th CROI Boston 2011 Abstract 871
73. S. Cleator, K. Fife, M. Nelson, B. Gazzard, R. Phillips, and M. Bower Treatment of HIV-associated invasive anal cancer with combined chemoradiation Eur J Cancer 36 2000 754 758
74. E.Y. Chiao, T.P. Giordano, P. Richardson, and H.B. El-Serag Human immunodeficiency virus associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era J Clin Oncol 26 2008 474 479
75. J.M. Palefsky Anal cancer prevention in HIV-positive men and women Curr Opin Oncol 21 2009 433 438
76. M. Berry, N. Jay, R. Cranston, T. Darragh, E. Holly, and M. Welton Progression of high-grade intraepithelial neoplasis to invasive anal cancer among HIV+ men who have sex with men 16th CROI Montreal 2009 Abstract 867
77. C. Hoffman, M. Sabransky, C. Wyen, A. Baumgarten, M. Hensel, and J. Bogner Clinical characteristics and outcome of HIV+ patients with invasive anal cancer 18th CROI Boston 2011 Abstract 870
78. M. Trastoy, P. Viciana, M. Fontillón, M. Sánchez Agüera, M.C. Ortega, and M.F. López Cortés Primeros 6 meses de biopsia anal con anoscopio en pacientes HSH VIH+: ¿primer o segundo paso diagnóstico? III Congreso Nacional de GESIDA y 5. Reunión Docente de la RIS. Sevilla 2011 Abstract PO-38
79. J.M. Palefsky, A.R. Giuliano, S. Goldstone, E.D. Moreira Jr., C. Aranda, and H. Jessen HPV vaccine against HPV infection and anal intraepithelial neoplasia N Engl J Med 365 2011 1576 1585
80. T. Wilkin, J.Y. Lee, S.Y. Lensing, E.A. Stier, S.E. Goldstone, and J.M. Berry Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men J Infect Dis 202 2010 1246 1253
81. CDC Recommendations on the use of quadrivalent human papillomavirus vaccine in males-Advisory Committee on Immunization Practices (ACIP), 2011 MMWR 60 2011 1705 1708
82. G. Ramírez-Olivencia, M.E. Valencia-Ortega, L. Martin-Carbonero, V. Moreno-Celda, and J. González-Lahoz Tumores en pacientes con infección por el virus de la inmunodeficiencia humana: estudio de 139 casos Med Clin (Barc) 133 2009 729 735
83. A.E. Grulich Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation Curr Opin HIV AIDS 4 2009 183 187
84. F. Bonnet, C. Burty, C. Lewden, D. Costagliola, T. May, and V. Bouteloup Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey Clin Infect Dis 48 2009 633 639
85. J. Murillas, M. Del Río, M. Riera, P. Vaquer, A. Salas, and M. Leyes Increased incidence of hepatocellular carcinoma (HCC) in HIV-1 infected patients Eur J Intern Med 16 2005 113 115
86. N. Bräu, R.K. Fox, and P. Xiao Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study J Hepatol 47 2007 527 537
87. J. García-Samaniego, M. Rodríguez, J. Berenguer, R. Rodriguez-Rosado, J. Carbó, and V. Asensi Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C Am J Gastroenterol 96 2001 179 183
88. a Reunión Docente de la RIS. Sevilla 2011 Abstract P-019
89. M. Guzmán-Fulgencio, J. Berenguer, I.F. de Castro, D. Micheloud, J.C. López, and J. Cosín Sustained virological response to interferon-α plus ribavirin decreases inflammation and endothelial dysfunction markers in HIV/HCV co-infected patients J Antimicrob Chemother 66 2011 645 649
90. F. Di Benedetto, N. De Ruvo, M. Berretta, M. Masetti, R. Montalti, and S. Di Sandro Hepatocellular carcinoma in HIV patients treated by liver transplantation Eur J Surg Oncol 34 2008 422 427
91. R. Bruno, M. Puoti, P. Sacchi, C. Filice, G. Carosi, and G. Filice Management of hepatocellular carcinoma in human immunodeficiency virus infected patients J Hepatol 44 Suppl. 1 2006 S146 S150
92. L. Rafael-Valdivia, J.M. Miró, and A. Rimola Trasplante hepático en pacientes con infección por VIH Gastroenterol Hepatol 33 2010 660 669
93. M. Salhab, and R. Canelo An overview of evidence-based management of hepatocellular carcinoma: A meta-analysis J Cancer Res Ther 7 2011 463 475
94. S.F. Oluwole, A.O. Ali, Z. Shafaee, and H.A. DePaz Breast cancer in women with HIV/AIDS: report of five cases with a review of the literature J Surg Oncol 89 2005 23 27
95. J.J. Goedert, C. Schairer, T.S. McNeel, N.A. Hessol, C.S. Rabkin, and E.A. Engels Risk of breast, ovary, and uterine corpus cancers among 85.268 women with AIDS Br J Cancer 95 2006 642 648
96. M. Ruiz, and H. Davis Breast cancer in HIV-infected patients: a retrospective single-institution study J Int Assoc Physicians AIDS Care (chic) 10 2011 30 34
97. N.A. Hessol, L.A. Napolitano, D. Smith, Y. Lie, A. Levine, and M. Young HIV tropism and decreased risk of breast cancer PLoS One 12 2010 e14349
98. B.E. Gewurz, B.J. Dezube, and L. Pantanowitz HIV and the breast AIDS Read 15 2005 399 402
99. J. Stebbing, S.E. Krown, M. Bower, A. Batra, S. Slater, and D. Serraino Primary esophageal carcinoma in the era of highly active antiretroviral therapy Arch Intern Med 170 2010 203 207
100. J.F. Yeguez, S.A. Martinez, D.R. Sands, L.R. Sands, and M.D. Hellinger Colorectal malignancies in HIV-positive patients Am Surg 69 2003 981 987
101. C. Chapman, D.M. Aboulafia, B.J. Dezube, and L. Pantanowitz Human immunodeficiency virus associated adenocarcinoma of the colon: clinicopathologic findings and outcome Clin Colorectal Cancer 8 2009 215 219
102. M. Alfa-Wali, D. Tait, T. Allen-Mersch, P. Tekkis, M. Nelson, and J. Stebbing Colorectal cancer in HIV positive individuals: The immunological effects of treatment Eur J Cancer 47 2011 2403 2407
103. E. Casolati, A. Agarossi, M. Valieri, and E. Ferrazzi Vulvar neoplasia in HIV positive women: a review Med Wieku Rozwoj 74 2003 487 493
104. J. Mork, A. Lie, E. Glattre, G. Hallmans, E. Jellum, and P. Koskela Human papilloma virus infection as a risk factor for squamous cell carcinoma of the head and neck N Engl J Med 344 2001 1125 1131
105. C. Ateenyi-Agaba Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda Lancet 345 1995 695 696
106. R. Newton A review of the aetiology of squamous cell carcinoma of the conjunctiva Br J Cancer 74 1996 1511 1513
107. M. Silverberg, W. Leyden, L. Xu, C. Chao, M. Horberg, and D. Klein ART use and risk of cancer in HIV patients 18th CROI Boston 2011 Abstract 81
108. M. Bruyand, R. Thiébaut, S. Lawson-Ayayi, P. Joly, A.J. Sasco, and P. Mercié Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Resercher sur le SIDA (ANRS) CO3 Aquitaine Cohort Clin Infect Dis 47 2009 1109 1116
109. N. Crum-Cianfione, K. Huppler, V. Marconi, A. Weintrob, A. Ganesan, and R.V. Barthel Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study AIDS 23 2009 41 50
110. R.J. Biggar, E.A. Engels, S. Ly, A. Khan, M.J. Schymura, and J. Sackoff Survival after cancer diagnosis in persons with AIDS J Acquir Immune Defic Syndr 39 2005 293 299
111. A. Cingolani, L. Torti, C. Pinnetti, K. de Gaetano Donati, R. Murri, and E. Tacconelli Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastin in HIV-infected patients with Hodgkin lymphoma J Intern AIDS Soc 13 Suppl. 4 2010 P215
112. M.E. Valencia AIDS-related malignancies: a new approach AIDS Rev 10 2008 125 126
113. C. Emmanouilides, and J. Glaspy Opportunistic infections in oncologic patients Hematol Oncol Clin North Am 10 1996 841 860
114. Miró JM, coordinador. Prevención de las infecciones oportunistas en pacientes adultos y adolescentes infectados por el VIH en el año 2008. Recomendaciones del Grupo de Estudio del Sida (GESIDA)/Plan Nacional sobre el Sida. Panel de expertos de GESIDA y Plan Nacional sobre el SIDA. Enferm Infecc Microbiol Clin. 2008;26:437-64.